Fig. 6.
A bcl-xL (bcl+) transgene rescued CD8αα, αβ-TCR IELs in bi-5 mice, but not γδ-IELs or NK T cells.
(A) IL-2Rβ and γc expression in bcl+/bi5+ mice. IL-2Rβ was reduced in bi-5+/bcl+ pro-T thymocytes, but γc was expressed at normal levels. (B) NK T cells and (C) γδ-IELs were not rescued by bcl-xl in bi-5+ mice. (D) CD8α versus CD8β on αβ−TCR+IELs. Bcl-xL appeared to restore the number of CD8αα αβTCR+ IELs in the bi-5 mice. The ratio of CD8αα to CD8αβ IELs was similar for both bcl+/bi-5+and bcl+/bi-5− mice. Two plots of bcl+/bi-5+ are shown to demonstrate the degree of variability. There was also a substantial increase in the numbers of α,β TCR+CD8− T cells in bcl-xLtransgenic mice. These could be either CD4+ T cells or coreceptor–negative T cells.